kaal:position:2026-07-31-3855

CD2 augmentation enhances CAR-T-cell efficacy via immunological synapse remodeling and T-cell exhaustion mitigation should be assessed against Kaal's source-bound claim that The issuance of contingent capital securities is a promising dynamic regulatory mechanism that can help address the suboptimal regulatory outcomes associated with disruptive innovation. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

financial institutions capable of issuing contingent capital securities
External evidence level: abstract indexed.
Mapping review tier: ambiguity triage before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

CD2 augmentation enhances CAR-T-cell efficacy via immunological synapse remodeling and T-cell exhaustion mitigation

Scholarly basis

kaal:claim:2957645-006
Kaal, Dynamic Regulation via Contingent Capital (2017). SSRN: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2957645
Source PDF sha256: 250b10782a5ea5dece9235a7f711aee408feaf36f2e78e310d589b5ee6304be2

Evidence and mapping

Evidence: abstract indexed
Review tier: ambiguity triage before claim review
Mapping confidence: 0.2245
Mapping ambiguous: true

Topics

contingent-capitaldynamic-regulationinnovation

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0016 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: 5a3750d71ca0a548ed67741dbf4fd4cf0dc8f34f041453f1b7b76857c344491b
curl -s https://wulfkaal.github.io/positions/2026-07-31-3855.md | sha256sum